Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study

• Hoofdauteurs: Thibaud Mathis (Auteur), Maxence Papegaey (Auteur), Cécile Ricard (Auteur), Amina Rezkallah (Auteur), Frédéric Matonti (Auteur), Aditya Sudhalkar (Auteur), Cristina Vartin (Auteur), Corinne Dot (Auteur), Laurent Kodjikian (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2022-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Diabetic macular edema (DME) is the main cause of visual impairment in diabetic patients and a chronic disease requiring long-term treatments. The fluocinolone acetonide (FAc) implant has recently been approved to treat DME in patients considered insufficiently responsive to available therapies. Thi...